information on new approvals and medication safety
Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis
Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.
Partners in Advancing Rheumatology
The REF is making great strides in advancing treatment and finding cures for rheumatic disease.
EULAR 2012: Does Arthritis Start in the Gut?
New research on the ties between bacteria and inflammatory disease.
Educational Leader Honored with Top Rheumatology Award
Paul Emery, MA, MD, receives prestigious Nachman Prize.
The Forward View in Rheumatology
Future leaders convene at the ACR/Arthritis Foundation Rheumatology Research Workshop to discuss cutting-edge research and career development.
Drug Updates
Information on new approvals and medication safety.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Tech Talk: Apps Put More Rheumatology Information at Fingertips
With more and more mobile devices and apps coming onto the market, more and more information is available to rheumatologists on the go.
A Rheumatologic Perspective on Intimacy and Chronic Illness
Sexual dysfunction is frequently one of the first manifestations of physical illness, but is often not inquired about on routine reviews of systems.